2022 AMI Online Salon

TIM-3 Graphic Novel

Project Details

  • Entrant Name:  Trisha Haszel Kreibich
  • Client: Novartis
  • Copyright: Novartis, 2021
  • Medium/software used: Adobe Illustrator/Photoshop
  • Final presentation format: Web, tablet, print, & installation
  • Primary Audience: Health care professionals (Hematologists)

Project Description

TIM-3 is a target of interest in certain hematologic malignancies such as AML and MDS. Though awareness is growing, a thorough understanding of the role TIM-3 plays in these diseases is not well understood in the hematology community. Our task was to develop an innovative style and method of teaching hematologists that TIM-3 expression on both immune and malignant cells provides a unique potential therapeutic pathway. Our approach had to be clear and accurate, but also cut through the noise around major congresses regarding new pathways under investigation. The approach also had to be flexible enough for leveraging through multiple channels (web, print, interactive installation, etc).